BRAF and metastatic malignant neoplasm in the lymph nodes: Information regarding BRAF mutational status, histological subtype, clinical risk, presence of lymph node metastases, clinical tumor stage, presence of extra-thyroidal extension, age and gender were used to create different PCA plots.